The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.

BACKGROUND The prognosis of the oral squamous cell carcinoma (OSCC) patients remains very poor, mainly due to their high propensity to invade and metastasize. E-cadherin reduced expression occurs in the primary step of oral tumour progression and gene methylation is a mode by which the expression of this protein is regulated in cancers. In this perspective, we investigated E-cadherin gene (CDH1) promoter methylation status in OSCC and its correlation with Ecadherin protein expression, clinicopathological characteristics and patient outcome. METHODS Histologically proven OSCC and paired normal mucosa were analyzed for CDH1 promoter methylation status and E-cadherin protein expression by methylation-specific polymerase chain reaction and immunohistochemistry. Colocalization of E-cadherin with epidermal growth factor (EGF) receptor (EGFR) was evidenced by confocal microscopy and by immunoprecipitation analyses. RESULTS This study indicated E-cadherin protein down-regulation in OSCC associated with protein delocalization from membrane to cytoplasm. Low E-cadherin expression correlated to aggressive, poorly differentiated, high grade carcinomas and low patient survival. Moreover, protein down-regulation appeared to be due to E-cadherin mRNA downregulation and CDH1 promoter hypermethylation. In an in vitro model of OSCC the treatment with EGF caused internalization and co-localization of E-cadherin with EGFR and the addition of demethylating agents increased E-cadherin expression. CONCLUSION Low E-Cadherin expression is a negative prognostic factor of OSCC and is likely due to the hypermethylation of CDH1 promoter. The delocalization of E-cadherin from membrane to cytoplasm could be also due to the increased expression of EGFR in OSCC and the consequent increase of E-cadherin co-internalization with EGFR.

[1]  S. Ceccarelli,et al.  TNFα Modulates Fibroblast Growth Factor Receptor 2 Gene Expression through the pRB/E2F1 Pathway: Identification of a Non-Canonical E2F Binding Motif , 2013, PloS one.

[2]  A. Papavassiliou,et al.  Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis—correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met , 2013, Tumor Biology.

[3]  G. Botti,et al.  Current treatment of cutaneous squamous cancer and molecular strategies for its sensitization to new target-based drugs , 2013, Expert opinion on biological therapy.

[4]  H. Ohdan,et al.  Liver–intestine cadherin induction by epidermal growth factor receptor is associated with intestinal differentiation of gastric cancer , 2012, Cancer science.

[5]  G. Botti,et al.  pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma , 2012, Cancer biology & therapy.

[6]  A. Fiorelli,et al.  Interplay between steroid receptors and neoplastic progression in sarcoma tumors , 2011, Journal of cellular physiology.

[7]  M. Guida,et al.  Epigenetic fingerprint in endometrial carcinogenesis: The hypothesis of a uterine field cancerization , 2011, Cancer biology & therapy.

[8]  G. Botti,et al.  GPR30 is overexpressed in post-puberal testicular germ cell tumors , 2011, Cancer biology & therapy.

[9]  E. Lobenhofer,et al.  Comparative epigenomics of human and mouse mammary tumors , 2009, Genes, chromosomes & cancer.

[10]  A. Wells,et al.  E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas , 2008, Clinical & Experimental Metastasis.

[11]  R. Franco,et al.  PATZ1 gene has a critical role in the spermatogenesis and testicular tumours , 2008, The Journal of pathology.

[12]  S. Serra,et al.  Membrane loss and aberrant nuclear localization of E‐cadherin are consistent features of solid pseudopapillary tumour of the pancreas. An immunohistochemical study using two antibodies recognizing different domains of the E‐cadherin molecule , 2008, Histopathology.

[13]  I. Nishimoto,et al.  E‐cadherin abnormalities resulting from CPG methylation promoter in metastatic and nonmetastatic oral cancer , 2008, Head & neck.

[14]  K. Kimura,et al.  Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. , 2007, The Journal of clinical investigation.

[15]  L. Mao,et al.  Promoter methylation as a common mechanism for inactivating E‐cadherin in human salivary gland adenoid cystic carcinoma , 2007, Cancer.

[16]  R. Kalluri,et al.  Mechanisms of metastasis: Epithelial‐to‐mesenchymal transition and contribution of tumor microenvironment , 2007, Journal of cellular biochemistry.

[17]  B. Gumbiner,et al.  Regulation of cadherin-mediated adhesion in morphogenesis , 2005, Nature Reviews Molecular Cell Biology.

[18]  A. Hall,et al.  Association of CNK1 with Rho Guanine Nucleotide Exchange Factors Controls Signaling Specificity Downstream of Rho , 2005, Current Biology.

[19]  L. Frati,et al.  Differential response to keratinocyte growth factor receptor and epidermal growth factor receptor ligands of proliferating and differentiating intestinal epithelial cells , 2004, Journal of cellular physiology.

[20]  R. Kramer,et al.  Promoter methylation regulates cadherin switching in squamous cell carcinoma. , 2004, Biochemical and biophysical research communications.

[21]  Tony Hunter,et al.  Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. , 2003, Cancer cell.

[22]  N. Pećina-Šlaus.  Tumor suppressor gene E-cadherin and its role in normal and malignant cells , 2003, Cancer Cell International.

[23]  R. Nagler,et al.  Squamous cell carcinoma of the tongue: the prevalence and prognostic roles of p53, Bcl-2, c-erbB-2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study. , 2002, Cancer letters.

[24]  C. Compton,et al.  TNM residual tumor classification revisited , 2002, Cancer.

[25]  K. Lam,et al.  Loss of E‐cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance , 2002, Cancer.

[26]  Tony Hunter,et al.  Epidermal Growth Factor-Induced Tumor Cell Invasion and Metastasis Initiated by Dephosphorylation and Downregulation of Focal Adhesion Kinase , 2001, Molecular and Cellular Biology.

[27]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[28]  K. Uzawa,et al.  Reduced expression of E-cadherin in oral squamous cell carcinoma: relationship with DNA methylation of 5' CpG island. , 1998, International journal of oncology.

[29]  A. Agresti.  [A Survey of Exact Inference for Contingency Tables]: Rejoinder , 1992 .

[30]  P. Goodfellow,et al.  Characterization and chromosomal localization of the gene encoding the human cell adhesion molecule uvomorulin. , 1988, Differentiation; research in biological diversity.

[31]  Joseph A Califano,et al.  Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. , 2006, The Lancet. Oncology.